Stem definition | Drug id | CAS RN |
---|---|---|
antibiotics, cefalosporanic acid derivatives | 574 | 153-61-7 |
Dose | Unit | Route |
---|---|---|
4 | g | P |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 3 | Benet LZ, Broccatelli F, Oprea TI |
S (Water solubility) | 50 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 52 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 252.24 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 0 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Vd (Volume of distribution) | 0.07 L/kg | Lombardo F, Berellini G, Obach RS |
CL (Clearance) | 1.80 mL/min/kg | Lombardo F, Berellini G, Obach RS |
fu (Fraction unbound in plasma) | 0.22 % | Lombardo F, Berellini G, Obach RS |
t_half (Half-life) | 0.95 hours | Lombardo F, Berellini G, Obach RS |
Date | Agency | Company | Orphan |
---|---|---|---|
Dec. 18, 1974 | FDA | LILLY |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | J01DB03 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE OTHER BETA-LACTAM ANTIBACTERIALS First-generation cephalosporins |
MeSH PA | D000900 | Anti-Bacterial Agents |
MeSH PA | D000890 | Anti-Infective Agents |
CHEBI has role | CHEBI:33281 | antibiotics |
CHEBI has role | CHEBI:36047 | antibacterial drugs |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Bacterial septicemia | indication | 10001005 | DOID:0040085 |
Infection of skin AND/OR subcutaneous tissue | indication | 19824006 | |
Pneumonia due to Streptococcus | indication | 34020007 | |
Lower respiratory tract infection | indication | 50417007 | |
Urinary tract infectious disease | indication | 68566005 | |
Haemophilus influenzae pneumonia | indication | 70036007 | |
Infection of bone | indication | 111253001 | |
Female genital tract infection | indication | 125585007 | |
Bacterial infection due to Klebsiella pneumoniae | indication | 186435004 | |
Pneumonia | indication | 233604007 | DOID:552 |
Infectious disorder of joint | indication | 363162000 | |
Genitourinary Tract Infections | indication | ||
Prevention of Perioperative Infection | indication |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 2.39 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Solute carrier family 22 member 8 | Transporter | INHIBITOR | IC50 | 7.59 | IUPHAR | ||||
Matrix metalloproteinase-9 | Enzyme | IC50 | 4.66 | WOMBAT-PK | |||||
Prostaglandin G/H synthase 2 | Enzyme | IC50 | 4.70 | WOMBAT-PK | |||||
Somatostatin receptor type 4 | GPCR | IC50 | 4.40 | WOMBAT-PK | |||||
Tyrosine-protein phosphatase non-receptor type 7 | Enzyme | IC50 | 6.04 | WOMBAT-PK | |||||
Solute carrier family 22 member 11 | Transporter | INHIBITOR | Ki | 6.70 | IUPHAR | ||||
Bacterial penicillin-binding protein | Enzyme | INHIBITOR | CHEMBL | CHEMBL | |||||
Penicillin-binding protein 1A | Enzyme | WOMBAT-PK |
ID | Source |
---|---|
4017538 | VUID |
N0000178975 | NUI |
D00907 | KEGG_DRUG |
58-71-9 | SECONDARY_CAS_RN |
2236 | RXNORM |
C0007735 | UMLSCUI |
CHEBI:124991 | CHEBI |
CLS | PDB_CHEM_ID |
CHEMBL1632 | ChEMBL_ID |
CHEMBL617 | ChEMBL_ID |
DB00456 | DRUGBANK_ID |
8798 | IUPHAR_LIGAND_ID |
6024 | PUBCHEM_CID |
3072 | MMSL |
4395 | MMSL |
d00186 | MMSL |
002712 | NDDF |
004840 | NDDF |
373485007 | SNOMEDCT_US |
37628007 | SNOMEDCT_US |
59937009 | SNOMEDCT_US |
D002512 | MESH_DESCRIPTOR_UI |
1477 | INN_ID |
4017538 | VANDF |
4019669 | VANDF |
C22G6EYP8B | UNII |
None